White Paper

Functional Comparability of a Biosimilar

Format: PDF file | Document type: White Paper | Promoted Content

This content is provided by SGS, and any views and opinions expressed do not necessarily reflect those of www.biopharma-reporter.com


Regulatory authorities require head-to-head comparison at multiple levels to demonstrate that a proposed biosimilar is “similar or highly similar” to the reference product. Structural and functional characterization is essential to demonstrating biosimilarity prior to further clinical development. Decisions based on factors observed during initial analytical screening could result in a shortened clinical development process.

Download this paper to learn about an alternative assay which provides time and cost savings during the functional characterization stage of development.